Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems
McGeer, P.L.; McGeer, E.G.; Hattori, T.
Advances in Biochemical Psychopharmacology 16: 397-402
1977
ISSN/ISBN: 0065-2229 PMID: 329651 Document Number: 110459
Document emailed within 1 workday
Related Documents
Bartholini, G.; Scatton, B.; Worms, P.; Zivkovic, B.; Lloyd, K.G. 1981: Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems Advances in Biochemical Psychopharmacology 30: 119-128Böttger, G.; Schmidt, J. 1980: Effects of striatum stimulation and micro-iontophoretically applied dopamine and acetylcholine on the neuronal activity of the globus pallidus Acta Biologica et Medica Germanica 39(1): 123-131
Hanson, G.R.; Singh, N.; Bush, L.; Gibb, J.W. 1991: Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine Journal of Pharmacology and Experimental Therapeutics 259(3): 1197-1202
Carrieri, P. 1977: GABA and diseases of the extrapyramidal system Acta Neurologica 32(5): 697-704
Parker, E.M.; Cubeddu, L.X. 1986: Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores Journal of Pharmacology and Experimental Therapeutics 237(1): 179-192
Faradzhev, A.N. 1988: The effect of starvation on GABA-transaminase and glutamate decarboxylase activity on mitochondria of dog limbic structures during postnatal ontogenesis Voprosy Meditsinskoi Khimii 34(6): 32-36
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Barkhatova, V.P.; Kandel', E.I.; Demina, E.G. 1981: Approaches to the study of dopamine metabolism in various extrapyramidal diseases Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 81(7): 1021-1029
Bartholini, G.; Keller, H.H.; Pletscher, A. 1975: Drug-induced changes of dopamine turnover in striatum and limbic system of the rat Journal of Pharmacy and Pharmacology 27(6): 439-442
Bugera-Piecuch, T.E.; Kosicka, B.; Kittel, M.; Smiałek, M. 1987: GABA synthesis in the central nervous system of rats with extrapyramidal syndrome after acute cobalt acetate poisoning in cerebral ischemia Neuropatologia Polska 25(1): 59-69
Mantovani, P.; Santicioli, P.; Pepeu, G. 1982: Effect of GABA-mimetic drugs on acetylcholine release in vitro Acta Physiologica et Pharmacologica Bulgarica 8(1-2): 24-28
Schoemaker, H.; Claustre, Y.; Fage, D.; Rouquier, L.; Chergui, K.; Curet, O.; Oblin, A.; Gonon, F.; Carter, C.; Benavides, J.; Scatton, B. 1997: Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity Journal of Pharmacology and Experimental Therapeutics 280(1): 83-97
Buscaino, G.A.; Mandarini, A.; Campanella, G.; Carrieri, P.; Orefice, G. 1976: Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes Acta Neurologica 31(5): 565-570
Kish, S.; Rajput, A.; Gilbert, J.; Rozdilsky, B.; Chang, L.J.; Shannak, K.; Hornykiewicz, O. 1987: GABA-dopamine relationship in Parkinson's disease striatum Advances in Neurology 45: 75-77
Nakazono, Y.; Abe, H.; Murakami, H.; Koyabu, N.; Isaka, Y.; Nemoto, Y.; Murata, S.; Tsutsumi, Y.; Ohtani, H.; Sawada, Y. 2005: Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(4): 163-171
Midgley, L.P.; Bush, L.G.; Gibb, J.W.; Hanson, G.R. 1993: Differential regulation of neuropeptide Y systems in limbic structures of the rat Journal of Pharmacology and Experimental Therapeutics 267(2): 707-713
Regenthal, R.; Kunstler, U.; Hesse, S.; Sabri, O.; Preiss, R. 2005: D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(8): 370-378
Ziablintseva, E.A.; Pavlova, I.V. 2009: Influence of GABA agonist phenibut on the neuronal activity and interaction in hippocampus and neocortex in emotionally negative situations Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 95(9): 907-918
Carroll, B.J. 1974: Role of acetylcholine and dopamine in manic behavior Psychopharmacology Bulletin 10(3): 51-52
Duvoisin, R.M.; Heinemann, S.F. 1993: Transcription control elements of the rat neuronal nicotinic acetylcholine receptor subunit alpha 3 Brazilian Journal of Medical and Biological Research 26(2): 137-150